Rachel Park, Author at ViewusGlobal

Rachel Park (630 Posts)

• 
  Trouble Sleeping? Your Personality Might Be the Reason Why 2025.05.23 A study links insomnia to emotional anxiety and personality traits, highlighting the need for psychological approaches over medication.
• 
  Lack of Iron Could Be Doing More Harm Than You Think 2025.05.21 A study links iron deficiency anemia to increased ischemic stroke risk in young adults, highlighting urgent screening needs.
• 
  New Study Blames Dirty Air and Few Trees for More Asthma Cases 2025.05.21 New research reveals air pollution and urban density significantly raise asthma risk, urging better urban planning for health improvement.
• 
  Can’t Smell That? Science Says It Might Mean More Than You Think 2025.05.20 A study reveals that olfactory decline may indicate mortality risk, linking diminished smell to health issues and increased death rates.
• 
  High School Athletes With ADHD Face Slower Concussion Recovery 2025.05.17 High school athletes with ADHD take longer to recover from concussions, requiring tailored support for safe return to activities.
• 
  Could One Brain Fix Help Anxiety, Depression, and Insomnia? 2025.05.16 New research links insomnia, depression, and anxiety to shared brain pathways, suggesting unified treatment strategies may be possible.
• 
  Sleep Apnea May Be Quietly Damaging Your Brain, New Study Finds 2025.05.15 A study links obstructive sleep apnea to memory decline, highlighting its impact on brain aging and cognitive changes.
• 
  FDA Approves Heart Valve Device for Patients Without Symptoms 2025.05.15 FDA approves SAPIEN 3 for asymptomatic severe aortic stenosis, shifting treatment strategies for better patient outcomes.
• 
  Danone to Remove Artificial Coloring From U.S. Yogurt Lines 2025.05.13 Danone plans to remove artificial colors from U.S. yogurt brands, aligning with health initiatives and consumer demand for cleaner ingredients.
• 
  Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA 2025.05.08 The FDA has delayed Novavax's COVID-19 vaccine approval, requiring more trials to prove its effectiveness after external interference.
• 
  Scientists Find Brain Switch That Could Help Reverse Memory Loss 2025.04.23 A study reveals SIRT2's role in memory decline in dementia, proposing a treatment targeting astrocytes to restore memory function.
• 
  New Blood Test Could Spot Alzheimer’s Early—With 92% Accuracy 2025.04.22 A breakthrough in Alzheimer's research reveals a blood test measuring MTBR-tau243 could enable early diagnosis and monitoring of the disease.
• 
  Lilly’s Weight-Loss Pill Looks Strong in Trials—Ozempic’s Reign in Jeopardy? 2025.04.22 Eli Lilly's new diabetes pill matches Ozempic's effectiveness, with hopes for regulatory approval and a growing obesity treatment market.
• 
  New Warning: Antidepressants Could Increase Risk of Fatal Heart Event 2025.04.18 A study links antidepressant use to increased sudden cardiac death risk, especially in younger adults, but depression also plays a role.
• 
  4:3 Fasting Helps Shed More Pounds Than Daily Dieting, Says New Study 2025.04.18 A study shows that 4:3 intermittent fasting leads to greater weight loss than daily calorie restriction over 12 months.
• 
  Why Cancer Risk Soars After a Type 2 Diabetes Diagnosis—Even Without Obesity 2025.04.17 Newly diagnosed type 2 diabetes significantly raises the risk of obesity-related cancers, necessitating early cancer screenings for patients.
• 
  Is 'Bad' Cholesterol Messing with Your Brain? New Study Says Yes 2025.04.16 Lower LDL cholesterol levels may reduce dementia risk, with a study showing significant differences in Alzheimer's rates based on cholesterol levels.
• 
  Want to Lose Weight? Trick Your Brain with These Simple Diet Hacks! 2025.04.03 Trick your body for effective dieting by using methods like fasting and visual portion control to manage cravings and promote weight loss.
• 
  Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds 2025.04.03 Prostate cancer screening can cut mortality rates by 50%, highlighting the need for early detection through PSA testing among high-risk men.
• 
  Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout 2025.04.03 Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.